Peering Into Altimmune's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Altimmune (NYSE:ALT) has seen a 41.55% increase in short interest since its last report, with 17.73 million shares sold short, representing 25.21% of its float. This places Altimmune's short interest significantly above its peer group average of 12.27%. The rise in short interest suggests a bearish market sentiment towards ALT, but it's also noted that an increase in short interest can sometimes be bullish.
April 30, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Altimmune's significant rise in short interest to 25.21% of its float indicates a bearish market sentiment but could also suggest a potential bullish reversal if shorts are squeezed.
The increase in short interest for Altimmune suggests that the market sentiment is currently bearish, reflecting a lack of confidence from investors. However, high short interest can lead to a short squeeze, potentially driving the stock price up if the market conditions change or if there's positive news about the company. The impact is considered neutral in the short term due to these opposing potential outcomes.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100